200 related articles for article (PubMed ID: 13281402)
1. [Phenylpropyl hydroxycoumarin as anticoagulant in obstetric and gynecological thrombophlebitis and its antidote, vitamin K1].
DE DOMINICIS E; ROLANDI L
Riv Ostet Ginecol Prat; 1955 Nov; 37(11):658-65. PubMed ID: 13281402
[No Abstract] [Full Text] [Related]
2. [Decrease of hemorrhagic accidents in anticoagulant therapy with coumarin derivatives by administration of vitamin K1].
THEDERING F; BOWING G
Munch Med Wochenschr; 1956 Mar; 98(10):340-4. PubMed ID: 13334377
[No Abstract] [Full Text] [Related]
3. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
GEILL T; LUND E; DAM H; SØNDERGAARD E
Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
[No Abstract] [Full Text] [Related]
4. [Clinical study of the anticoagulant 3-(1-phenylpropyl)-4-hydroxycoumarin or marcoumar and of its antidote, vitamin K1].
GAGLIARDI L
Minerva Ginecol; 1954 Jan; 6(2):84-97. PubMed ID: 13154044
[No Abstract] [Full Text] [Related]
5. [Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis].
PERCESEPE E
Rass Int Clin Ter; 1956 Jul; 36(14):419-24. PubMed ID: 13379678
[No Abstract] [Full Text] [Related]
6. [Progress in management of dicumarol therapy; simplification of control; vitamin KI as antidote].
KOLLER F; LOELIGER A; FLUCKIGER P
Helv Med Acta; 1952 Oct; 19(4-5):411-6. PubMed ID: 13021791
[No Abstract] [Full Text] [Related]
7. [The control of dangerous effects of coumarin with vitamin K1 (konakion)].
THIES HA
Medizinische; 1955 Oct; (40):1411-5. PubMed ID: 13272564
[No Abstract] [Full Text] [Related]
8. [Clinical studies on the new anticoagulant, marcoumar, and its antagonist, konakion (vitamin K1)].
GAGLIARDI L
Gynaecologia; 1954 Sep; 138(3):424-40. PubMed ID: 13210728
[No Abstract] [Full Text] [Related]
9. [Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1].
SOULIER JP; SOULLARD J
Sang; 1952; 23(8):709-14. PubMed ID: 13004931
[No Abstract] [Full Text] [Related]
10. The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan.
VAN BUSKIRK WC
N Engl J Med; 1953 Jan; 248(2):57-8. PubMed ID: 13002683
[No Abstract] [Full Text] [Related]
11. [Remarks on P. Bockel and K. D. Schmidt's paper Accident in anticoagulant therapy].
SARTORI C
Munch Med Wochenschr; 1955 Sep; 97(37):1219-20. PubMed ID: 13265728
[No Abstract] [Full Text] [Related]
12. Clinical experiences with 4-hydroxycoumarin anticoagulant No. 63 and the antagonistic effect of menadione and vitamin K.
HANSON HH; BARKER NW; MANN FD
Circulation; 1951 Dec; 4(6):844-63. PubMed ID: 14879492
[No Abstract] [Full Text] [Related]
13. Vitamin K as an antidote to decumarol?
VERSTRAETE M
Belg Tijdschr Geneesk; 1952 Oct; 8(19):884-9. PubMed ID: 13008956
[No Abstract] [Full Text] [Related]
14. [Vitamin K1 as an anticoagulant].
Dia Med; 1953 Aug; 25(57):1599-1600. PubMed ID: 13095210
[No Abstract] [Full Text] [Related]
15. A new highly active anticoagulant with prolonged effect (marcoumar).
KOLLER F; JAKOB H
Schweiz Med Wochenschr; 1953 May; 83(20):476-9. PubMed ID: 13076082
[No Abstract] [Full Text] [Related]
16. [Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].
JURGENS R
Schweiz Med Wochenschr; 1953 May; 83(20):471-5. PubMed ID: 13076081
[No Abstract] [Full Text] [Related]
17. The control of excessive effect by anticoagulants.
DUFF IF; GAMBLE JR; WILLIS PW; HODGSON PE; WILSON WS; POLHEMUS JA
Ann Intern Med; 1955 Nov; 43(5):955-78. PubMed ID: 13268991
[No Abstract] [Full Text] [Related]
18. [Clinical study of the possibility of percutaneous anticoagulant therapy of some forms of venous phlogosis caused by obstetrical and gynecological conditions].
FOTI M
Quad Clin Ostet Ginecol; 1956 Aug; 11(8):492-504. PubMed ID: 13370827
[No Abstract] [Full Text] [Related]
19. Small doses of vitamin K1 for correction of reduced prothrombin activity.
SCHIRGER A; SPITTEL JA; RAGEN PA
Proc Staff Meet Mayo Clin; 1959 Sep; 34():453-8. PubMed ID: 14442821
[No Abstract] [Full Text] [Related]
20. Vitamin K intake and stability of oral anticoagulant treatment.
Oldenburg J
Thromb Haemost; 2005 May; 93(5):799-800. PubMed ID: 15886790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
